Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-08

Clinical Trial Update: Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of the VDMN-21 Patch in subjects with verruca vulgaris (common warts) has completed, reporting safety and effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VDMN-21 Patch (VDMN-21)

Snippet

Sponsor: Veradermics, Inc. | Conditions: Verruca Vulgaris, Warts | Phase 2 | Status: COMPLETED